What is [D-Lys³] GHRP-6 (Ectotropin)? [D-Lys³] GHRP-6 is a Ghrelin and GHRP-6 antagonist (anti-Ghrelin). An antagonist is an opposing or resistant structure in relation and tends to neutralize or impede some action or effect. In this case, the [D-Lys³] GHRP-6 is actually a selective antagonist of the cognate ghrelin receptor, i.e. the GH-secretagogue receptor (GSR).
Studies have shown that clinical administration of [D-Lys³] GHRP-6 effectively decreased appetite, decreased body fat , lowered glucose blood levels, increased lean skeletal muscle, and lowered cholesterol, triglycerides, and free fatty acids. The remarkable potential of this peptide is for blocking receptor bonding of ghrelin. When weight loss is desired, many drawbacks in today's available forms of appetite suppressing diet aids are that the body still continuously signals production of ghrelin. Ghrelin is actually produced and binds at a more rapid rate when the body goes into a fasting or dieting state. Some forms of obesity have been linked to higher production levels of ghrelin which trigger appetite stimulation and faster gastric emptying (in layman's term, quicker release of food into digestion and out of stomach, allowing more space to eat again and sooner). This creates a constant struggle for dieters trying to reduce food intake because their body is actually responding to their change in diet and reduction of calories by increasing production of ghrelin. When the appetite has been suppressed during dieting without also suppressing ghrelin (such as stimulant type appetite suppressants), a dieter will actually have higher levels than prior to their diet, causing a quicker increase of appetite and stored weight gain when the appetite suppressing supplement is discontinued.
Another positive finding is the decreased glucose levels after repeated administration; with less glucose to burn the body is able to burn stored and/or fat intake. The sustained increase in skeletal muscle mass is relative to the increase in growth hormone production which further support the positive beneficial health findings due to supplementation of this remarkable peptide. Clinical studies and active research related to this peptide continue to show the potential base for a safer, alternative to supplemental diet products.
What Is Cell-Mediated Delivery?
Cell_mediated technology facilitates gene expression, cell-mediated endocytosis through intracellular signal pathways. Break down: cell-mediated means that the biological cells in the lymphatics are what is allowing the IGF-1 to absorb into the blood. You could have syringe mediated, digestion mediated or other EXTRAcelluar forms of mediation. Our formulation is INTRAcelluar mediated. Cell mediation is “gene expressed.” This means that the cell mediation occurs from a specific gene that acts as a “switch.” The sentence above goes further by implying that the “gene expressed, cell mediation” is achieved “through intracellular signal pathways.” This means that the “gene expressed” that causes the “cell mediation” is similar to an electrical signal that turns the cell on or off, hence signaling.
Cell-mediated technology has been clinically proven to have 24 to 48 hour sustainability. This sustainability is due to the expressed signaling that occurs on a cellular level. This signaling allows the composition to be delivered in intervals for 24 to 48 hours. This product is like nothing else seen on the market in regards to sustainability and dose effectiveness. Degradation and deterioration of vital aminos and peptides will no longer hold us back.